Allogeneic th1 cells home to host bone marrow and spleen and mediate ifnγ-dependent aplasia

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 6, 2013, Pages 876-887

  Chewning, Joseph H ^a   Zhang, Weiwei ^a   Randolph, David A ^b   Swindle, C Scott ^c   Schoeb, Trenton R ^d   Weaver, Casey T ^e  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e University of Alabama at Birmingham   (United States)

Author keywords

Bone marrow failure; Graft versus host disease; Hematopoietic stem cell transplantation Mouse models; Th1 cells

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CD4+ T LYMPHOCYTE; CELL AGGREGATION; CELL HOMING; CELL MATURATION; CONTROLLED STUDY; GRAFT VERSUS HOST REACTION; INTRACELLULAR SIGNALING; LYMPHOCYTE ACTIVATION; LYMPHOID TISSUE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REPORTER GENE; SPLEEN; TH1 CELL;

ANIMALS; BONE MARROW; BONE MARROW CELLS; CELL COMMUNICATION; FEMALE; GENE EXPRESSION; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY TESTING; HUMANS; INTERFERON-GAMMA; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MODELS, ANIMAL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RECEPTORS, CXCR4; RED-CELL APLASIA, PURE; SPLEEN; TH1 CELLS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84877900074     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2013.03.007     Document Type: Article

References (53)

1. Wolff S.N. Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation. Bone Marrow Transplant 2002, 29:545-552.
2. Larocca A., Piaggio G., Podesta M., et al. Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation. Haematologica 2006, 91:935-940.
3. Carlson M.J., West M.L., Coghill J.M., et al. In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations. Blood 2009, 113:1365-1374.
4. Fowler D.H., Kurasawa K., Smith R., et al. Donor CD4-enriched cells of Th2 cytokine phenotype regulate graft-versus-host disease without impairing allogeneic engraftment in sublethally irradiated mice. Blood 1994, 84:3540-3549.
5. Krenger W., Snyder K.M., Byon J.C., et al. Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease. J Immunol 1995, 155:585-593.
6. Fowler D.H., Breglio J., Nagel G., et al. Allospecific CD4+, Th1/Th2 and CD8+, Tc1/Tc2 populations in murine GVL: type I cells generate GVL and type II cells abrogate GVL. Biol Blood Marrow Transplant 1996, 2:118-125.
7. Zeis M., Uharek L., Hartung G., et al. Graft-vs-leukemia activity and graft-vs-host disease induced by allogeneic Th1- and Th2-type CD4+ T cells in mice. Hematol J 2001, 2:136-144.
8. Hatton R.D., Harrington L.E., Luther R.J., et al. A distal conserved sequence element controls Ifng gene expression by T cells and NK cells. Immunity 2006, 25:717-729.
9. Szabo S.J., Kim S.T., Costa G.L., et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000, 100:655-669.
10. Solomou E.E., Keyvanfar K., Young N.S. T-bet, a Th1 transcription factor, is up-regulated in T cells from patients with aplastic anemia. Blood 2006, 107:3983-3991.
11. Bloom M.L., Wolk A.G., Simon-Stoos K.L., et al. A mouse model of lymphocyte infusion-induced bone marrow failure. Exp Hematol 2004, 32:1163-1172.
12. Sprent J., Surh C.D., Agus D., et al. Profound atrophy of the bone marrow reflecting major histocompatibility complex class II-restricted destruction of stem cells by CD4+ cells. J Exp Med 1994, 180:307-317.
13. Welniak L.A., Blazar B.R., Anver M.R., et al. Opposing roles of interferon-gamma on CD4+ T cell-mediated graft-versus-host disease: effects of conditioning. Biol Blood Marrow Transplant 2000, 6:604-612.
14. Tary-Lehmann M., Rolink A.G., Lehmann P.V., et al. Induction of graft versus host-associated immunodeficiency by CD4+ T cell clones. J Immunol 1990, 145:2092-2098.
15. Wang H., Asavaroengchai W., Yeap B.Y., et al. Paradoxical effects of IFN-gamma in graft-versus-host disease reflect promotion of lymphohematopoietic graft-versus-host reactions and inhibition of epithelial tissue injury. Blood 2009, 113:3612-3619.
16. Chen J., Lipovsky K., Ellison F.M., et al. Bystander destruction of hematopoietic progenitor and stem cells in a mouse model of infusion-induced bone marrow failure. Blood 2004, 104:1671-1678.
17. Yang L., Dybedal I., Bryder D., et al. IFN-gamma negatively modulates self-renewal of repopulating human hemopoietic stem cells. J Immunol 2005, 174:752-757.
18. Delisle J.S., Gaboury L., Belanger M.P., et al. Graft-versus-host disease causes failure of donor hematopoiesis and lymphopoiesis in interferon-gamma receptor-deficient hosts. Blood 2008, 112:2111-2119.
19. Baker M.B., Riley R.L., Podack E.R., Levy R.B. Graft-versus-host-disease-associated lymphoid hypoplasia and B cell dysfunction is dependent upon donor T cell-mediated Fas-ligand function, but not perforin function. Proc Natl Acad Sci U S A 1997, 94:1366-1371.
20. Shono Y., Ueha S., Wang Y., et al. Bone marrow graft-versus-host disease: early destruction of hematopoietic niche after MHC-mismatched hematopoietic stem cell transplantation. Blood 2010, 115:5401-5411.
21. Maynard C.L., Harrington L.E., Janowski K.M., et al. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10. Nat Immunol 2007, 8:931-941.
22. McKenzie I.F., Morgan G.M., Sandrin M.S., et al. B6.C-H-2bm12. A new H-2 mutation in the I region in the mouse. J Exp Med 1979, 150:1323-1338.
23. Sprent J., Schaefer M., Lo D., Korngold R. Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences. J Exp Med 1986, 163:998-1011.
24. Murphy W.J., Welniak L.A., Taub D.D., et al. Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice. J Clin Invest 1998, 102:1742-1748.
25. Nikolic B., Lee S., Bronson R.T., et al. Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets. J Clin Invest 2000, 105:1289-1298.
26. Burman A.C., Banovic T., Kuns R.D., et al. IFNgamma differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract. Blood 2007, 110:1064-1072.
27. Backstrom B.T., Muller U., Hausmann B., Palmer E. Positive selection through a motif in the alphabeta T cell receptor. Science 1998, 281:835-838.
28. O'Shaughnessy M.J., Chen Z.M., Gramaglia I., et al. Elevation of intracellular cyclic AMP in alloreactive CD4(+) T Cells induces alloantigen-specific tolerance that can prevent GVHD lethality in vivo. Biol Blood Marrow Transplant 2007, 13:530-542.
29. Kondo M., Weissman I.L., Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 1997, 91:661-672.
30. Forster R., Schubel A., Breitfeld D., et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999, 99:23-33.
31. Pepper M., Jenkins M.K. Origins of CD4(+) effector and central memory T cells. Nat Immunol 2011, 12:467-471.
32. Sawada S., Gowrishankar K., Kitamura R., et al. Disturbed CD4+ T cell homeostasis and in vitro HIV-1 susceptibility in transgenic mice expressing T cell line-tropic HIV-1 receptors. J Exp Med 1998, 187:1439-1449.
33. Tavor S., Petit I., Porozov S., et al. CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice. Cancer Res 2004, 64:2817-2824.
34. Tanaka Y., Imai T., Baba M., et al. Selective expression of liver and activation-regulated chemokine (LARC) in intestinal epithelium in mice and humans. Eur J Immunol 1999, 29:633-642.
35. Zabel B.A., Agace W.W., Campbell J.J., et al. Human G protein-coupled receptor GPR-9-6/CC chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis. J Exp Med 1999, 190:1241-1256.
36. Loetscher P., Uguccioni M., Bordoli L., et al. CCR5 is characteristic of Th1 lymphocytes. Nature 1998, 391:344-345.
37. Bonecchi R., Bianchi G., Bordignon P.P., et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998, 187:129-134.
38. Muller A., Homey B., Soto H., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56.
39. Castro-Malaspina H., Gay R.E., Resnick G., et al. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 1980, 56:289-301.
40. Chen M.F., Lin C.T., Chen W.C., et al. The sensitivity of human mesenchymal stem cells to ionizing radiation. Int J Radiat Oncol Biol Phys 2006, 66:244-253.
41. Omokaro S.O., Desierto M.J., Eckhaus M.A., et al. Lymphocytes with aberrant expression of Fas or Fas ligand attenuate immune bone marrow failure in a mouse model. J Immunol 2009, 182:3414-3422.
42. Koyama M., Kuns R.D., Olver S.D., et al. Recipient nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-host disease. Nat Med 2012, 18:135-142.
43. Toubai T., Tawara I., Sun Y., et al. Induction of acute GVHD by sex-mismatched H-Y antigens in the absence of functional radiosensitive host hematopoietic-derived antigen-presenting cells. Blood 2012, 119:3844-3853.
44. Bernabei P., Allione A., Rigamonti L., et al. Regulation of interferon-gamma receptor (INF-gammaR) chains: a peculiar way to rule the life and death of human lymphocytes. Eur Cytokine Netw 2001, 12:6-14.
45. Belyaev N.N., Brown D.E., Diaz A.I., et al. Induction of an IL7-R(+)c-Kit(hi) myelolymphoid progenitor critically dependent on IFN-gamma signaling during acute malaria. Nat Immunol 2010, 11:477-485.
46. Patrussi L., Baldari C.T. Intracellular mediators of CXCR4-dependent signaling in T cells. Immunol Lett 2008, 115:75-82.
47. Suzuki Y., Rahman M., Mitsuya H. Diverse transcriptional response of CD4(+) T cells to stromal cell-derived factor (SDF)-1: cell survival promotion and priming effects of SDF-1 on CD4(+) T cells. J Immunol 2001, 167:3064-3073.
48. Yi T., Chen Y., Wang L., et al. Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease. Blood 2009, 114:3101-3112.
49. Das R., Chen X., Komorowski R., et al. Interleukin-23 secretion by donor antigen-presenting cells is critical for organ-specific pathology in graft-versus-host disease. Blood 2009, 113:2352-2362.
50. Mauermann N., Burian J., von Garnier C., et al. Interferon-gamma regulates idiopathic pneumonia syndrome, a Th17+CD4+ T-cell-mediated graft-versus-host disease. Am J Respir Crit Care Med 2008, 178:379-388.
51. Pan L., Delmonte J., Jalonen C.K., Ferrara J.L. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood 1995, 86:4422-4429.
52. Pan L., Teshima T., Hill G.R., et al. Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease. Blood 1999, 93:4071-4078.
53. Hill G.R., Olver S.D., Kuns R.D., et al. Stem cell mobilization with G-CSF induces type 17 differentiation and promotes scleroderma. Blood 2010, 116:819-828.